Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. - Wikidata - awgldk - TriplyDB

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

http://www.wikidata.org/entity/Q33335630

about

Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics Developments in the identification of glycan biomarkers for the detection of cancer Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines Glycosylated VCAM-1 isoforms revealed in 2D western blots of HUVECs treated with tumoral soluble factors of breast cancer cells.Alterations in the serum glycome due to metastatic prostate cancer Pancreatic cancer serum detection using a lectin/glyco-antibody array method Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients Use of activated graphitized carbon chips for liquid chromatography/mass spectrometric and tandem mass spectrometric analysis of tryptic glycopeptides.Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.The N-glycome of human embryonic stem cells.Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.Protein modifications as potential biomarkers in breast cancer.Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling.High-mannose glycans are elevated during breast cancer progression Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform.Plasma membrane proteomics and its application in clinical cancer biomarker discovery.Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.N-glycan profiling by microchip electrophoresis to differentiate disease states related to esophageal adenocarcinoma.CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations The sweet and sour of serological glycoprotein tumor biomarker quantification.Glycomic profiling of tissue sections by LC-MS Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry.Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS.A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinoma MALDI mass spectrometry-based sequence analysis of arginine-containing glycopeptides: improved fragmentation of glycan and peptide chains by modifying arginine residue.Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.One-Year Plasma N-linked Glycome Intra-individual and Inter-individual Variability in the Chicken Model of Spontaneous Ovarian Adenocarcinoma.The emerging importance of α-L-fucose in human breast cancer: a review.Aberrant glycosylation associated with enzymes as cancer biomarkers.Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.Protein biomarkers for the early detection of breast cancer.N-Glycan profiling of dried blood spots Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MS

P2860

Q26778227-648E327E-9CEA-4E5F-AAA6-DCAC0494A9D5 Q27026715-8F84EEC2-C1DD-4565-878D-C5D6B3AC98B0 Q28079101-815D4E72-8F18-4660-A2FF-7A37D23A725C Q30529166-3359F700-0F02-48AD-B847-FE699028C2B0 Q30907649-D0224D37-B3F8-4ACB-99C9-7E1C7B70EAD3 Q33282042-1ECD71F9-7B0C-4EE1-A44B-225C591E6E4B Q33391974-DA077E6E-FF00-4516-9D26-38FEC3CFAF87 Q33396321-747250CD-AA9A-4DBB-ADF2-E14AF44F0E28 Q33400004-87D5BDF7-1941-4271-858F-71A285BE7967 Q33456015-103161F2-92D8-4778-8D9A-8E2AEA62A39B Q33458926-90DCB523-D415-4EEE-B757-E267E98243AD Q33546544-ECA56C8B-525B-491D-907E-F6EDB42A57CA Q33586407-F1C25D39-8AC0-44E4-B91F-AD209C1A947B Q33653461-2E9A3205-4529-4B2B-86A1-504A112AE972 Q33753523-406E521D-A8D5-4025-A72D-72534F9C8C05 Q33778489-09228D8E-D811-46F1-9E8D-96DB0D4EC567 Q33836040-89817FA5-C576-4FE6-B56E-659E1BAE883D Q33995843-5656197C-4BB8-4CFE-9A59-697CF422EDB0 Q34022368-739BCE97-AFC6-4F5E-A8A9-5F827C60E8CB Q34080008-3DDC5A2F-F1CA-4712-9AE5-A16A7EE98C29 Q34122107-670CCFA2-89FE-429D-B46A-41F045E9CB18 Q34129290-CBE0501C-B8AF-4C98-9DF9-4C3D3696283A Q34187614-C259B1FA-33CC-4A5E-89DF-F97720EAF7A3 Q34404795-490809A1-D813-4794-868D-6A530C02E652 Q34580285-D35503DF-1EBC-4D03-B1BB-05766C40FCA4 Q34601075-867E5A8F-86CE-4FAC-9D6A-E3385D696F84 Q34621113-CCE948A4-F70E-46E9-A47B-ECD446279B6B Q34775343-B2014A2B-164F-4537-98C3-6FA7BDD0DAE0 Q34808751-CADFE889-B4FA-49ED-B01C-6A72D52E6811 Q34871683-7E666235-519B-4A64-9708-F223B3F2BB57 Q34975642-67CF58A0-60A9-4CCF-BE9E-7EC3159F440A Q35161829-814D156B-DFB7-42C8-B8FF-8D1F2F1ACD93 Q35172546-40FBBC8C-BE84-4815-A92C-FEDFBFAEB671 Q35206309-699329DA-C181-4D60-AC17-8CE4F475BEB0 Q35262822-7D237181-1721-4E69-ABE8-36317DE133EA Q35367572-03A51F87-88D8-424D-A796-0C4B452E430D Q35675417-62FD172D-8730-4646-B848-9A775B4C5C33 Q35874074-28A5AED0-E688-48EF-95CC-D9EA630C6778 Q35874750-C21DBABB-B43B-49C7-BAAB-835D351913D7 Q35886419-6E5876E0-10FD-41B7-9560-E81E22BD19B8

P2860

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

http://www.wikidata.org/entity/Q33335630

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@ast

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@en

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@nl

type

label

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@ast

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@en

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@nl

prefLabel

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@ast

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@en

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@nl

P1433

Q33335630-2E5E2650-33BA-4C1C-93A1-F6C16DDF9372

P1476

Q33335630-5F3E8CA6-E134-48EE-99D7-2F9EB14F617C

P2093

Q33335630-4B662846-FC09-417C-8176-53CED6D4E062

Q33335630-5989F3D7-BCAE-4F65-BC71-FDC93C257013

Q33335630-5AFAE38A-A70B-45A9-BCF3-211D26DA2796

Q33335630-72CA1F07-1763-4A0B-9465-63D837C49A99

Q33335630-8D7F0D9A-09F9-4924-91D8-63218F52D1A6

Q33335630-ADD4FD3C-A0B6-41C1-A461-14EA6D67E1CB

Q33335630-C425D0A8-E71D-488A-87A3-5D6A6004B3F3

Q33335630-D17C92EF-C4A8-42F0-BBB0-E0DE2AC86DCF

Q33335630-F443FB50-2B9D-4C85-8FD5-B5FF5D16421F

P304

Q33335630-3EB93D3D-9A16-4248-884A-D25829358BA6

P31

Q33335630-330CB37F-2CFB-40EC-9980-D750C6E3B586

P356

Q33335630-314F3223-E688-4E5C-B498-01C94F04E0DF

P407

Q33335630-7E7161EC-BFED-4564-8951-4C41B33F1349

P433

Q33335630-C6062D1C-4EA8-4CD5-A1DD-C97C03E7EB0E

P478

Q33335630-5486EB4F-316B-461E-B233-CC637BFBED0B

P50

Q33335630-36D0F743-C363-4CBE-BB96-FB7407EA8C46

P577

Q33335630-6E22F2CF-C9F4-4FEF-B05F-5D65E63100A4

P5875

Q33335630-B2B2E97D-77B2-4136-9C4E-09FBF4736E95

P698

Q33335630-E802EED4-3F0F-453A-BB7A-045BAD8AF103

P921

Q33335630-387182a8-28fe-4530-968b-a882ae34610c

P356

CLINCHEM.2007.087148

P1433

Clinical Chemistry

P1476

Breast cancer diagnosis and pr ...... ents of serum glycan profiles.

@en

P2093

George W Sledge

http://www.w3.org/2001/XMLSchema#string

John A Goetz

http://www.w3.org/2001/XMLSchema#string

Lacey E Dobrolecki

http://www.w3.org/2001/XMLSchema#string

Lauren Schnaper

http://www.w3.org/2001/XMLSchema#string

Linda H Malkas

http://www.w3.org/2001/XMLSchema#string

Milos V Novotny

http://www.w3.org/2001/XMLSchema#string

Pilsoo Kang

http://www.w3.org/2001/XMLSchema#string

Robert J Hickey

http://www.w3.org/2001/XMLSchema#string

Zuzana Kyselova

http://www.w3.org/2001/XMLSchema#string

P304

1166-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2007.087148

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5363792

http://www.w3.org/2001/XMLSchema#string

P698

18487288

http://www.w3.org/2001/XMLSchema#string

P921